← Open Payments lookup

KATHYRN NOVAK: Open Payments

NPI 1265689715 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,333 in 28 payments from 12 companies in 2025. Trend: 2023 $1,435 · 2024 $1,094 · 2025 $1,333

Food & beverage: $1,333
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.4$194
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$184
Sage Therapeutics, LLC2$174
ABBVIE INC.4$162
Teva Pharmaceuticals USA, Inc.1$120
Otsuka America Pharmaceutical, Inc.4$109
Boehringer Ingelheim Pharmaceuticals, Inc.1$108
Axsome Therapeutics, Inc.1$105
Alkermes, Inc.3$73
Janssen Pharmaceuticals, Inc2$56

Products named: COBENFY, CAPLYTA, VRAYLAR, Auvelity, ABILIFY ASIMTUFII, ARISTADA, INVEGA SUSTENNA, REXULTI.

Industry payments across MD — which companies pay providers there.